148 related articles for article (PubMed ID: 12431237)
1. Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22).
Seftel MD; Bruyere H; Copland M; Hogge DE; Horsman DE; Nantel SH; Shepherd JD; Lavoie JC; Le A; Sutherland HJ; Toze CL; Nevill TJ
Eur J Haematol; 2002 Oct; 69(4):193-9. PubMed ID: 12431237
[TBL] [Abstract][Full Text] [Related]
2. [Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy].
Kikuchi T; Miyata A; Fujii S; Kikuchi T
Rinsho Ketsueki; 2003 Nov; 44(11):1113-6. PubMed ID: 14689878
[TBL] [Abstract][Full Text] [Related]
3. Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults.
Min GJ; Kim HJ; Yoon JH; Kwak DH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1621-1628. PubMed ID: 29698793
[TBL] [Abstract][Full Text] [Related]
4. [Acute myelomonocytic leukemia with inv (16) (p13 q22) disappeared abnormal karyotype during complete remission].
Tsushima Y; Yukita T; Mikami T; Takami H; Aihara M; Kawamura S; Yoshida Y; Chiba Y
Rinsho Ketsueki; 1989 Dec; 30(12):2178-82. PubMed ID: 2621800
[TBL] [Abstract][Full Text] [Related]
5. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
[TBL] [Abstract][Full Text] [Related]
6. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
7. Persistent molecular remission of refractory acute myeloid leukemia with inv(16)(p13.1q22) in an elderly patient induced by cytarabine ocfosfate hydrate.
Arahata M; Shimizu Y; Asakura H; Nakao S
J Hematol Oncol; 2015 Feb; 8():5. PubMed ID: 25652695
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of myeloperoxidase containing blast cells in acute myelogenous leukaemia.
Advani SH; Hegde UP; Iyer RS; Gopal R; Saikia TK; Pai SK; Nair CN; Kurkure PA; Pai VR; Nadkarni KS
Indian J Med Res; 1993 Feb; 98():8-14. PubMed ID: 8388366
[TBL] [Abstract][Full Text] [Related]
9. Lymphoid blastic crisis of chronic myelogenous leukaemia with inv(16)(p13;q22).
Tsuboi K; Komatsu H; Miwa H; Iida S; Banno S; Wakita A; Nitta M; Ueda R
Leuk Res; 2002 Aug; 26(8):771-4. PubMed ID: 12191573
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature.
Betts DR; Rohatiner AZ; Evans ML; Rassam SM; Lister TA; Gibbons B
Leukemia; 1992 Dec; 6(12):1250-6. PubMed ID: 1453770
[TBL] [Abstract][Full Text] [Related]
11. Diffuse alveolar hemorrhage during induction therapy for acute myeloid leukemia with inv(16)(p13.1q22).
Kanaya M; Kondo T
Int J Hematol; 2020 Aug; 112(2):134-135. PubMed ID: 32506319
[No Abstract] [Full Text] [Related]
12. Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia.
Eghtedar A; Borthakur G; Ravandi F; Jabbour E; Cortes J; Pierce S; Kantarjian H; Garcia-Manero G
Am J Hematol; 2012 Mar; 87(3):317-8. PubMed ID: 22228403
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL
J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025
[TBL] [Abstract][Full Text] [Related]
14. Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside.
Ghaddar HM; Plunkett W; Kantarjian HM; Pierce S; Freireich EJ; Keating MJ; Estey EH
Leukemia; 1994 Aug; 8(8):1269-74. PubMed ID: 8057660
[TBL] [Abstract][Full Text] [Related]
15. [High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22)].
Kumagawa M; Suzuki K; Nagano M; Takamatsu Y; Suzumiya J; Tamura K
Rinsho Ketsueki; 2003 Jun; 44(6):404-6. PubMed ID: 12884821
[TBL] [Abstract][Full Text] [Related]
16. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia].
Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485
[TBL] [Abstract][Full Text] [Related]
17. A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
Mato AR; Riccio BE; Qin L; Heitjan DF; Carroll M; Loren A; Porter DL; Perl A; Stadtmauer E; Tsai D; Gewirtz A; Luger SM
Leuk Lymphoma; 2006 May; 47(5):877-83. PubMed ID: 16753873
[TBL] [Abstract][Full Text] [Related]
18. Continuous intravenous administration of daunorubicin and cytarabine for remission induction of poor risk acute myelogenous leukaemias and myelodysplastic syndromes.
Bär BM; de Witte T; de Pauw BE; Haanen C
Neth J Med; 1990 Feb; 36(1-2):19-24. PubMed ID: 2314517
[TBL] [Abstract][Full Text] [Related]
19. Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature.
Zhang XH; Zhang R; Li Y
Leuk Res; 2010 Jul; 34(7):958-61. PubMed ID: 20116851
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults.
Kornblau SM; Gandhi V; Andreeff HM; Beran M; Kantarjian HM; Koller CA; O'Brien S; Plunkett W; Estey E
Leukemia; 1996 Oct; 10(10):1563-9. PubMed ID: 8847890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]